Wilmington, DE, June 29, 2022 — Enovis™, an innovation-driven medical technology company, announced today a strategic partnership with Kelvi™, an innovator of digital hot and cold therapy products, to deliver industry-leading heating and cooling therapies for rehabilitation, recovery and performance enhancement to patients and athletes of all abilities. As part of... Read more
Press Releases
Enovis Investor Relations: https://ir.enovis.com/
WILMINGTON, Del. — DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system consists of 37 anatomically designed plates throughout nine plate families, offering a plating solution for any ankle fracture.... Read more
Carlsbad, CA June 13, 2022 – Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its subsidiary, DJO, LLC has launched its new ProCare MaxTrax™ 2.0 and MaxTrax 2.0 Air Walking Boots. The MaxTrax 2.0 builds upon the company’s market-leading MaxTrax walking... Read more
Wilmington, DE, May 24, 2022 — Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its subsidiary, DJO, LLC, has acquired the assets of Outcome-Based Technologies, LLC. The move builds upon the DJO® (now part of Enovis) legacy of bracing innovation, and... Read more
Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on the New York Stock Exchange under the ticker symbols “ENOV” and “ESAB”, respectively. Read more
New Castle, Delaware, March 22, 2022 - Companion Animal Health, a global animal health company specializing in laser and rehabilitation therapies and on-site diagnostics in veterinary markets worldwide, and a division of DJO, today announced a strategic agreement, including an equity investment, with HT BioImaging to co-brand and exclusively sell... Read more
